Urgent Call to Secure Access to BDBV Therapeutics for Ebola Patients
Audio narration · Coming soon
This statement accompanies MSF Access’s technical brief on Ebola therapeutics, emphasizing the critical need to act promptly to ensure future availability of effective treatments. The focus is on securing access to these tools for the populations most urgently in need.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews
